We are live on ! Find out more
ODT

Odonate Therapeutics, Inc. Common Stock
ODT

Delisted

ODT was delisted on the 14th of January, 2022.

Back to rankings

82 hedge funds and large institutions have $818M invested in Odonate Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 14

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

6% more funds holding

Funds holding: 77 → 82 (+5)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

28% less capital invested

Capital invested by funds: $1.14B → $818M (-$322M)

Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
1.8%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
15
Increased
43
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.61M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.54M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.35M
4
State Street
State Street
Massachusetts
+$2.19M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.99M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$7.98M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.49M
3
Invesco
Invesco
Georgia
-$4.28M
4
SB
Samsara BioCapital
California
-$3.12M
5
OM
Opaleye Management
Massachusetts
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Artisan Partners
26
Artisan Partners
Wisconsin
$2.05M +$93.3K +2,789 +4%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$2.04M +$279K +8,323 +12%
OAM
28
Oxford Asset Management
United Kingdom
$1.94M +$856K +25,567 +52%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$1.82M +$2.35M +70,084 New
Charles Schwab
30
Charles Schwab
California
$1.8M +$466K +13,936 +25%
Two Sigma Investments
31
Two Sigma Investments
New York
$1.55M +$1.99M +59,481 New
Millennium Management
32
Millennium Management
New York
$1.44M +$1.51M +45,143 +441%
Goldman Sachs
33
Goldman Sachs
New York
$1.26M +$1.38M +41,183 +581%
N
34
Nuveen
North Carolina
$1.22M +$852K +25,453 +119%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.13M +$423K +12,633 +41%
EGI
36
EAM Global Investors
California
$1.06M +$1.36M +40,759 New
Allianz Asset Management
37
Allianz Asset Management
Germany
$1M -$508K -15,187 -28%
Bank of America
38
Bank of America
North Carolina
$867K +$875K +26,144 +367%
EI
39
EAM Investors
California
$822K +$1.06M +31,564 New
CIP
40
Chartwell Investment Partners
Pennsylvania
$795K – – –
TD Asset Management
41
TD Asset Management
Ontario, Canada
$781K +$53.4K +1,597 +6%
Ameriprise
42
Ameriprise
Minnesota
$738K -$1.69M -50,490 -64%
Swiss National Bank
43
Swiss National Bank
Switzerland
$692K +$475K +14,200 +115%
Renaissance Technologies
44
Renaissance Technologies
New York
$659K -$190K -5,674 -18%
Squarepoint
45
Squarepoint
New York
$636K +$475K +14,184 +138%
SO
46
STRS Ohio
Ohio
$559K +$224K +6,700 +45%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$546K +$702K +20,993 New
BC
48
Birchview Capital
Vermont
$521K – – –
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$476K +$212K +6,328 +53%
SIM
50
Spark Investment Management
New York
$450K +$253K +7,569 +78%
1
2
3 4

ODT Hedge Fund Activity: Q3 2019 in Review

82 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q3 2019, worth a combined $818M — down 28% from $1.14B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ODT positions and 9 closed out — a net gain of 6 holders — while 43 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $9.61M. The largest seller was Franklin Resources, cutting an estimated $7.98M.

  • 82 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q3 2019, up from 77 in Q2 2019.
  • Funds reported $818M of Odonate Therapeutics, Inc. Common Stock stock for Q3 2019, down 28% quarter-over-quarter.
  • 15 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of +6 holders.
  • The largest Odonate Therapeutics, Inc. Common Stock buyer in Q3 2019 was BlackRock, an estimated $9.61M added.
  • The largest Odonate Therapeutics, Inc. Common Stock seller in Q3 2019 was Franklin Resources, an estimated $7.98M sold.

Based on aggregated 13F filings for Q3 2019.